Category: Drug Discovery
Drug Discovery market research reports by DelveInsight
-
Complement C1 inhibitors - Pipeline Insight, 2025
DelveInsight’s, “Complement C1 Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Complement C1 Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers ... Read More
-
Potassium channel antagonists - Pipeline Insight, 2025
DelveInsight’s, “Potassium channel antagonists - Pipeline Insight, 2025” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Potassium channel antagonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025
DelveInsight’s, “Glucagon-Like Peptide 1 Receptor Agonists - Pipeline Insight, 2025” report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Glucagon-Like Peptide 1 Receptor Agonists pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclin ... Read More
-
Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist - Pipeline Insight, 2025
“Transient Receptor Potential Vanilloid 1 (TRPV-1) Receptor (Capsaicin Receptor or Vanilloid Receptor 1) Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Pot ... Read More
-
TYK2 kinase inhibitors - Pipeline Insight, 2025
DelveInsight’s, “TYK2 Kinase Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 15+ companies and 15+ pipeline drugs in TYK2 Kinase Inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers th ... Read More
-
Type 4 cyclic nucleotide phosphodiesterase inhibitors - Pipeline Insight, 2025
DelveInsight’s, “Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors - Pipeline Insight, 2025” report provides comprehensive insights about 20+ companies and 20+ pipeline drugs in Type 4 Cyclic Nucleotide Phosphodiesterase Inhibitors pipeline landscape. It covers the pipeline drug profiles, includ ... Read More
-
Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2025
“Transient Receptor Potential Cation Channel, Subfamily M, Member 8 (TRPM8) Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Transient Receptor Potential Cation Channel, Sub ... Read More
-
Sigma Receptor Agonist - Pipeline Insight, 2025
“Sigma Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Sigma Receptor Agonist development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2025
“Kv1.3 Potassium Channel Blockers - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Kv1.3 Potassium Channel Blockers development. The report provides detailed coverage of the pipeline l ... Read More
-
Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2025
“Interleukin-5 (IL-5) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-5 (IL-5) Inhibitor development. The report provides detailed coverage of the pipeline lands ... Read More
-
Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2025
DelveInsight’s, “Interleukin-18 (IL-18) Inhibitor - Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 4+ pipeline drugs in Interleukin-18 (IL-18) Inhibitor pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More
-
Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2025
“Interleukin-23 (IL-23) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Interleukin-23 (IL-23) Inhibitor development. The report provides detailed coverage of the pipeline l ... Read More
-
ATPase Inhibitor - Pipeline Insight, 2025
“ATPase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across ATPase Inhibitor development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2025
“Apolipoprotein B (ApoB) Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Apolipoprotein B (ApoB) Inhibitor development. The report provides detailed coverage of the pipeline ... Read More
-
Angiotensin Receptor Agonist - Pipeline Insight, 2025
“Angiotensin Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Angiotensin Receptor Agonist development. The report provides detailed coverage of the pipeline landscape ... Read More
-
AMPA Receptor Antagonist - Pipeline Insight, 2025
“AMPA Receptor Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across AMPA Receptor Antagonist development. The report provides detailed coverage of the pipeline landscape for thi ... Read More
-
Aldose Reductase Inhibitor - Pipeline Insight, 2025
“Aldose Reductase Inhibitor - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Aldose Reductase Inhibitor development. The report provides detailed coverage of the pipeline landscape for ... Read More
-
Aldosterone Antagonist - Pipeline Insight, 2025
“Aldosterone Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Aldosterone Antagonist development. The report provides detailed coverage of the pipeline landscape for this me ... Read More
-
Adenosine A3 Receptor Agonist - Pipeline Insight, 2025
“Adenosine A3 Receptor Agonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Adenosine A3 Receptor Agonist development. The report provides detailed coverage of the pipeline landsca ... Read More
-
5-HT7 Antagonist - Pipeline Insight, 2025
“5-HT7 Antagonist - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-HT7 Antagonist development. The report provides detailed coverage of the pipeline landscape for this mechanism of a ... Read More
-
5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2025
“5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) - Pipeline Insight, 2025” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across 5-Lipoxygenase Inhibitor (Arachidonate 5-Lipoxygenase Inhibitor) deve ... Read More
-
Oligometastatic Disease - Market Insights, Epidemiology, and Market Forecast - 2034
Key Highlights According to DelveInsight’s patient-based forecasting model, the oligometastatic disease market size in the 7MM was around USD 1,900 million in 2023, which is expected to significantly increase over the forecast period (2024-2034), owing to an increase in the cases and the launch of n ... Read More
-
Microbiome Disease- Pipeline Insight, 2025
DelveInsight’s, “Microbiome Disease- Pipeline Insight, 2025” report provides comprehensive insights about 140+ companies and 180+ pipeline drugs in Microbiome Disease pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the thera ... Read More
-
Metastatic Colorectal Cancer - Pipeline Insight, 2025
DelveInsight’s, “Metastatic Colorectal Cancer - Pipeline Insight, 2025” report provides comprehensive insights about 150+ companies and 180+ pipeline drugs in Metastatic Colorectal Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It ... Read More
-
Chronic Spinal Cord Injury- Pipeline Insight, 2025
DelveInsight’s, “Chronic Spinal Cord Injury- Pipeline Insight, 2025” report provides comprehensive insights about 4+ companies and 5+ pipeline drugs in Chronic Spinal Cord Injury pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also cove ... Read More
Research Assistance
